spacer
home > epc > spring 2002 > transformation from paper to electronic clinical trials - the site perspective
PUBLICATIONS
European Pharmaceutical Contractor

Transformation from Paper to Electronic Clinical Trials - The Site Perspective

Rising competitive pressures are forcing the drug development process to work at a faster and more efficient pace, shortening development cycles and increasing the demand for shorter data collection times. In response to this challenge, according to the Forrester report (1) in July 2001, more than 50 per cent of trial professionals would prefer to conduct clinical trials using web-enabled systems in place of paper and two-thirds think sponsors should make this change happen now.

The first stage in the successful implementation of a web-based trial process at the clinical investigation site is providing encouragement for the evolution of the users' mindset. If the process is continuously equated to a paper-based trial, problems will inevitably arise. We need to promote a new working environment at the user level, and introduce the new process at a rate and level appropriate to that of the user's previous experience, current resources and organisational culture. It is preferable to integrate the electronic concept gradually into the existing practice - this is an intricate challenge!

To maximise efficiency in a paper trial, the standard site's working ethos has evolved to working with batches of patient data. In contrast, e-trials often dictate that immediate data entry is required - resulting in the co-ordinator working on a 'per patient' basis. The difference in processing requirements between paper and electronic studies should be resolved during the study initiation or site set-up, to prevent unnecessary conflicting expectations within the study teams. Communication charts are particularly useful as more individuals become involved in e-trials (including technical support, help desk personnel and clinical staff).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Paul Webb, Commercial and Operations Director, and Nigel Trim, Managing Director of MATRIX contract research Limited

Paul Webb was appointed Commercial and Operations Director in 2000 with responsibility for bringing improved technology utilisation to MATRIX contract research Limited and its clients. He has over 12 years' experience of EDC, change management and business process re-engineering, gained through consultancy work with the world's leading aerospace and defence corporations.

Nigel Trim, a Pharmacologist, is Managing Director of MATRIX contract research Limited. He has previous experience as managing director of a medical IT company and of senior management in International Sales and Marketing, with particular experience in the use of the Internet, clinical research, the management of direct sales, global distribution networks, and in and out-licensing.


spacer
Paul Webb
spacer
spacer
spacer
Nigel Trim,
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement